FHIR IG Statistics: ValueSet/2.16.840.1.114222.4.11.7239

Resources that use this resource

No resources found

Resources that this resource uses

Narrative

No narrative content found in resource

Source

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.114222.4.11.7239",
  "meta": {
    "versionId": "5",
    "lastUpdated": "2023-12-21T17:43:03.000-05:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "CDC NHSN Author"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2025-02-21"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2020-08-07"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7239",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.114222.4.11.7239"
    }
  ],
  "version": "20200807",
  "name": "NHSNContraindicationType",
  "title": "NHSNContraindicationType",
  "status": "active",
  "experimental": false,
  "date": "2020-08-07T01:00:29-04:00",
  "publisher": "CDC NHSN",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: NHSN surveillance reporting: Contraindication for using chlorhexidine gluconate (CHG) for Central Line Insertion Practices (CLIP) adherence monitoring),(Data Element Scope: A coded observation value representing the type of contraindication.),(Inclusion Criteria: ),(Exclusion Criteria: )",
  "compose": {
    "include": [
      {
        "system": "https://www.cdc.gov/nhsn/cdaportal/terminology/codesystem/cdcnhsn.html",
        "concept": [
          {
            "code": "6131-7",
            "display": "Patient is less than 2 months of age - chlorhexidine gluconate is to be used with caution in patients less than 2 months of age"
          },
          {
            "code": "6132-5",
            "display": "Patient has a documented/known allergy/reaction to chlorhexidine gluconate-based products that would preclude its use"
          },
          {
            "code": "6133-3",
            "display": "Facility restrictions or safety concerns for chlorhexidine gluconate use in premature infants precludes its use"
          }
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:8a8e4548-9857-4e91-9e8f-152eea0f9f3c",
    "timestamp": "2025-05-23T23:55:55-04:00",
    "total": 3,
    "contains": [
      {
        "system": "https://www.cdc.gov/nhsn/cdaportal/terminology/codesystem/cdcnhsn.html",
        "version": "2023-04",
        "code": "6131-7",
        "display": "Patient is less than 2 months of age - chlorhexidine gluconate is to be used with caution in patients less than 2 months of age"
      },
      {
        "system": "https://www.cdc.gov/nhsn/cdaportal/terminology/codesystem/cdcnhsn.html",
        "version": "2023-04",
        "code": "6132-5",
        "display": "Patient has a documented/known allergy/reaction to chlorhexidine gluconate-based products that would preclude its use"
      },
      {
        "system": "https://www.cdc.gov/nhsn/cdaportal/terminology/codesystem/cdcnhsn.html",
        "version": "2023-04",
        "code": "6133-3",
        "display": "Facility restrictions or safety concerns for chlorhexidine gluconate use in premature infants precludes its use"
      }
    ]
  }
}